SREBP-regulated adipocyte lipogenesis is dependent on substrate availability and redox modulation of mTORC1.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31310592.
- Also identified by DOI 10.1172/jci.insight.129397 and PMC identifier 6693888.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The synthesis of lipid and sterol species through de novo lipogenesis (DNL) is regulated by two functionally overlapping but distinct transcription factors: the sterol regulatory element-binding proteins (SREBPs) and carbohydrate response element binding protein (ChREBP). ChREBP is considered to be the dominant regulator of DNL in adipose tissue (AT); however, the SREBPs are highly expressed and robustly regulated in adipocytes, suggesting that the model of AT DNL may be incomplete. Here we describe a new mouse model of inducible, adipocyte-specific overexpression of the insulin-induced gene 1 (Insig1), a negative regulator of SREBP transcriptional activity. Contrary to convention, Insig1 overexpression did block AT lipogenic gene expression. However, this was immediately met with a compensatory mechanism triggered by redox activation of mTORC1 to restore SREBP1 DNL gene expression. Thus, we demonstrate that SREBP1 activity sustains adipocyte lipogenesis, a conclusion that has been elusive due to the constitutive nature of current mouse models.
Medical subject headings
- Adipocytes
- Adipose Tissue
- Lipogenesis
- Mechanistic Target of Rapamycin Complex 1
- Sterol Regulatory Element Binding Proteins